The India–Oman CEPA enhances market access for Indian pharmaceutical products by enabling zero-duty treatment, quicker regulatory approvals, and more streamlined procedures.
Measures such as fast-track authorisations, mutual recognition of GMP standards, and simplified… pic.twitter.com/ILOI0tkppZ
